# ClinicalTrials.gov record history: NCT03856632

- Peptide profile: [liraglutide](https://peptidescanner.com/peptides/liraglutide/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct03856632-liraglutide/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/trials/nct03856632.json
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `385db59e0dbc12aee4daf110fc8b7300be6da22cbca58dbc931762c3d8518e59`

## Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

## Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2019-02-26 | 2019-02-26 | RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03856632?a=1&tab=history) | `d163c9f3630b3db627a75b951c0182e7a12c8a506b614bc4761fb23875453cc1` |
| 2 | 2019-04-16 | 2019-04-16 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03856632?a=2&tab=history) | `d913d3dc9366a245e5934d32478994d30769108808a85b0d3f019dbe5e6e9be4` |
| 3 | 2019-12-05 | 2019-12-05 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03856632?a=3&tab=history) | `77018feed3002818f1f78ca345e9a0856dab4676d0e8bf34ea4dd2a33e30d73c` |
| 4 | 2020-06-17 | 2020-06-17 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03856632?a=4&tab=history) | `724b5004ea8f83a6fa57291787011129306ef42af3382bb2cc1cd461f4502007` |
| 5 | 2020-12-21 | 2020-12-21 | RECRUITING | INTERVENTIONAL | Eligibility, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03856632?a=5&tab=history) | `928571500da1e4355382679b8db4d4a0b3d9734dd02c94fd4da8ab098aaf8b56` |
| 6 | 2021-05-03 | 2021-05-03 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03856632?a=6&tab=history) | `8ab18ed88bebf0a3b39162c2bad6c4660246fb9b8b3d5048c1d5c97e95721c86` |
| 7 | 2022-04-28 | 2022-04-28 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03856632?a=7&tab=history) | `95e0411c75cb082da59dfb7063ad590fd2ed1d43538402f88d17e54bde53ca2c` |
| 8 | 2023-04-18 | 2023-04-18 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03856632?a=8&tab=history) | `b4727fe72e1d0fbb069c56ab38957574f78500fa9a0292f01a3f0fe59d95a30c` |
| 9 | 2024-03-26 | 2024-03-26 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03856632?a=9&tab=history) | `df7d1941060282fcc9c8a373ccef7562cda16408e3b9e7870901a6c18ea5729b` |
| 10 | 2025-03-17 | 2025-03-17 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03856632?a=10&tab=history) | `0ebedfaa49d39217d95742148ebb7ff156254c17246a2f83babf928f3da74d73` |
| 11 | 2026-01-28 | 2026-01-28 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03856632?a=11&tab=history) | `fc1810bd71e751a8fd184db7a7e4bbd9b1b221f83f5f4c884fa8b28b782b3aa8` |
| 12 | 2026-04-27 | 2026-04-27 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03856632?a=12&tab=history) | `1516c54b004080bc31b5f9eef4ceb0546a6aca0ff587e1d87c7a19d551af3f1d` |